Home › Compare › CTCXW vs EPRT

CTCXW vs EPRT: Dividend Comparison 2026

CTCXW yields 7490.64% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CTCXW wins by $3219325239215192.50M in total portfolio value
10 years
CTCXW
CTCXW
● Live price
7490.64%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3219325239215192.50M
Annual income
$3,136,944,464,329,217,000,000.00
Full CTCXW calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — CTCXW vs EPRT

📍 CTCXW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTCXWEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTCXW + EPRT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CTCXW pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTCXW
Annual income on $10K today (after 15% tax)
$636,704.12/yr
After 10yr DRIP, annual income (after tax)
$2,666,402,794,679,834,000,000.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, CTCXW beats the other by $2,666,402,794,679,834,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTCXW + EPRT for your $10,000?

CTCXW: 50%EPRT: 50%
100% EPRT50/50100% CTCXW
Portfolio after 10yr
$1609662619607596.25M
Annual income
$1,568,472,232,164,608,400,000.00/yr
Blended yield
97.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

CTCXW
No analyst data
Altman Z
-38.0
Piotroski
4/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTCXW buys
0
EPRT buys
0
No recent congressional trades found for CTCXW or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTCXWEPRT
Forward yield7490.64% ✓3.97%
Annual dividend / share$2.00 ✓$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29% ✓
Portfolio after 10y$3219325239215192.50M ✓$64.3K
Annual income after 10y$3,136,944,464,329,217,000,000.00 ✓$13,170.85
Total dividends collected$3213812604182292.00M ✓$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CTCXW vs EPRT ($10,000, DRIP)

YearCTCXW PortfolioCTCXW Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$759,764$749,063.67$11,212$512.01+$748.6K → CTCXW
2$54,000,925$53,187,977.91$12,689$692.09+$53.99M → CTCXW
3$3,590,852,097$3,533,071,107.68$14,521$944.30+$3590.84M → CTCXW
4$223,408,125,107$219,565,913,362.68$16,841$1,302.88+$223408.11M → CTCXW
5$13,005,862,347,544$12,766,815,653,679.31$19,841$1,821.64+$13005862.33M → CTCXW
6$708,523,022,229,903$694,606,749,518,031.20$23,818$2,587.47+$708523022.21M → CTCXW
7$36,122,824,222,390,480$35,364,704,588,604,476.00$29,230$3,744.65+$36122824222.36M → CTCXW
8$1,723,706,063,164,109,000$1,685,054,641,246,151,400.00$36,816$5,540.38+$1723706063164.07M → CTCXW
9$76,991,378,398,107,710,000$75,147,012,910,522,120,000.00$47,806$8,413.17+$76991378398107.67M → CTCXW
10$3,219,325,239,215,192,500,000$3,136,944,464,329,217,000,000.00$64,324$13,170.85+$3219325239215192.50M → CTCXW

CTCXW vs EPRT: Complete Analysis 2026

CTCXW — Stock

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Full CTCXW Calculator →

EPRT — REIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this CTCXW vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTCXW vs SCHDCTCXW vs JEPICTCXW vs OCTCXW vs KOCTCXW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.